P
PCRX
Pacira BioSciences, Inc. Common Stock
$36.40
Current Price
1W
1M
3M
6M
1Y
All
AI analysis
Read what the AI thinks of Pacira BioSciences, Inc. Common Stock in the app.
Analyses are generated by AI from public data and are not investment advice.
Get the app
Key figures
Dividend per share
—
Yield
—
EPS
$0.35
P/E
68.5
Data as of Oct 8
Why it matters for the long term
Over 10-20 years, what drives a share up is the growth of its profits (EPS) + reinvested dividends. The P/E tells you whether you are paying a lot or a little for that growth. In short: rising EPS + reasonable P/E + growing dividend = good long-term candidate.
Upcoming events
Quarterly earnings
Expected EPS: $0.75
Nov 4
Posts
No posts about PCRX yet.
About Pacira BioSciences, Inc. Common Stock
Pacira Biosciences makes non-opioid pain medicines used in hospitals and surgery centers. Its two main products are Exparel, a long-acting injection given after surgery so patients need fewer opioid painkillers, and Zilretta, a shot for knee arthritis pain. The company earns money by selling these branded drugs directly to hospitals, surgical centers and doctors' offices across the United States.